Editas Medicine, Inc.
Long

EDIT - another genomics name that looks ready

271
All major gene editing stocks look like they're on the cusp of big moves higher. (See last post on NTLA)
NTLA - trend continuation likely


Zoomed in on the shorter time frame we have a trigger off the 618 4hr retrace. There's some overhead supply in the 50s for shorter term targets, but this is a long term play with much higher upside.
istantanea

Seeing similar in CRSP, but EDIT is showing a more significant breakout on the monthly time frame
Short term quick look at CRSP:
istantanea

NTLA is the leader in the sector right now, but that could change fast. I am long all three

Declinazione di responsabilità

Le informazioni e le pubblicazioni non sono intese come, e non costituiscono, consulenza o raccomandazioni finanziarie, di investimento, di trading o di altro tipo fornite o approvate da TradingView. Per ulteriori informazioni, consultare i Termini di utilizzo.